MEMPHIS, Tenn., May 20, 2005 (PRIMEZONE) -- Luminetx Corp. announced today that shareholders of the privately held, Memphis-based bioscience company have elected eight members to the corporation's board of directors.
Directors elected at the annual shareholders meeting come from diverse backgrounds including medicine, public health, investment banking, insurance, real estate and technology research and development.
"Our directors have distinguished themselves in their professions and by how they work to advance their industries and communities," said James M. Phillips, Luminetx chairman, president and chief executive officer. "Their leadership will help our company make a significant and sustained impact through our breakthrough products and technologies, both here at home and around the world."
The Board's election follows a successful financing round which raised $4 million for R&D and initial production of the company's premier product, the Luminetx VeinViewer(tm), which uses infrared light and patented technologies to visualize and project real-time images of patient's veins directly onto the surface of their skin.
Newly elected Luminetx Corporation directors are:
Calvin Anderson, 49, is vice president of federal and community relations for BlueCross BlueShield of Tennessee. He is chairman of the Memphis Redbirds Baseball Foundation and a member of the Tennessee State Election Commission. Previously, Mr. Anderson served in senior staff positions in the United States Senate for nearly a decade and in key sales and management posts in the insurance industry. He holds a BA from the University of Memphis. Mark Darty, 41, heads North American R&D for global consumer electronics firm Brother International Corp. He has created successful R&D enterprises in aerospace, automotive and consumer electronics and developed patents in power electronics, software engineering, display technology, microfluidics and nanotechnology. He holds a BS in Electrical Engineering from the University of Tennessee and a MS in Engineering from the University of Alabama. Michael D. Easterly, 58, serves as chairman and CEO of Legacy Securities Corp. of Atlanta. Mr. Easterly is a director of Internet Pictures Corp. (NASDAQ:IPIX), a trustee of the Wellington Group, LLC, a developer of assisted living facilities, and board chairman of the Georgia State University Foundation. Previously, he led investment and merchant banking at Morgan Keegan & Co. He has a BS from the University of Tennessee and MBA from Georgia State. Kimble L. Jenkins, 43, is a managing director with Morgan Keegan & Co.'s investment banking group and founder of Morgan Keegan's Private Equity Group. He helped lead successful start-ups at Medicis Pharmaceutical and Vital Trends, Inc. and directed operations at Ardent Studios. Mr. Jenkins is also interim CEO for SurgiVision. He holds a BA from Brown University and a JD from Georgetown University. Scott Morris, MD, M Div, 51, is an ordained Methodist minister who ministers to the region's working poor through the Church Health Center, the faith-based health center he founded in 1987 and leads as executive director. In addition, he is an author, columnist and widely published authority on matters of faith, health and public policy. Dr. Morris holds a BA from the University of Virginia, an M Div. from Yale University and an MD from Emory University. James M. Phillips, 53, is president, CEO and chairman of Luminetx Corp. Most recently, Mr. Phillips served as CEO in Residence for Morgan Keegan & Co. and as CEO and chairman of the FedEx Institute of Technology at the University of Memphis. Throughout his career, he led companies with pioneering technologies to become industry leaders, companies such as SkyTel, Motorola and iPIX. He received his BBA and MBA degrees from the University of Memphis. Edward P. Scott, MD, 56, is president and CEO of Lifeblood Mid-South Regional Blood Center. He served previously with the St. Paul, Minn.-area regional blood bank, where he helped establish the National Marrow Donor Program (NMDP), a non-profit organization and leading transplant registry. He serves on the boards of the NMDP, Mid-South Regional Blood Center, the Lifeblood Foundation and Blood Centers Exchange. A hematologist, he holds a BS from Mississippi State University and an MD from the University of Mississippi. John H. Trezevant, 53, is president and CEO of Trezevant Realty Corporation. Mr. Trezevant has been active in the planning, developing, financing, constructing, marketing and managing of office, commercial, retail and residential projects for the past 25 years. In the past decade, his companies have developed more than 3 million square feet of property in the Mid-South. He is a member of the Urban Land Institute and the International Council of Shopping Centers.
About Luminetx Corporation
Headquartered in the biotech district of Memphis, Tennessee, Luminetx Corporation discovers, develops, and commercializes bioscience technologies in the digital imaging, supply chain management, nanotech, wireless, and IP communications arenas. Luminetx's premier product, VeinViewer was recognized by Time Magazine as "one of the coolest medical inventions of the Year." Luminetx plans to make VeinViewer commercially available in early 2006. For more information visit the company's web site: www.luminetx.com